On August 10, 2022 The Asian Pacific Association for the Study of the Liver (APASL) will host the APASL Oncology 2022 meeting "Liver Cancer: Clinical and Basic Research" September 1-3, 2022 (Press release, LamKap Bio Group, AUG 10, 2022, View Source [SID1234618010]). LamKap Bio gamma reported to present for the first time preclinical data on the development of NILK-2501 (GPC3xCD3) and NILK-3801 (GPC3xCD28) bispecific antibodies for immunotherapy of patients with glypican-3 (GPC3) expressing solid tumors.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"Novel GPC3xCD3 (NILK-2501) and GPC3xCD28 (NILK-3801) κλ bispecific antibodies for next generation immunotherapy of GPC3-expressing cancer" will be presented on September 3 between 9:10-10:40 am JST (presentation no. WS27-2).

A pdf file will be made available for download after presentation at the meeting.